Back to Search
Start Over
ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients.
- Source :
- Journal of Infectious Diseases; 2023 Supplement, Vol. 288, pS77-S82, 6p
- Publication Year :
- 2023
-
Abstract
- Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 00221899
- Volume :
- 288
- Database :
- Complementary Index
- Journal :
- Journal of Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 171352168
- Full Text :
- https://doi.org/10.1093/infdis/jiad246